Pedskin Research child skin care

Treatment of Epidermolysis Bullosa

Is your child living with fragile or blister-prone skin?

A new clinical trial is now enrolling children with Simplex Epidermolysis Bullosa to help advance research and care.

About the Treatment

Epidermolysis Bullosa Simplex Trial:

Testing Diacerein 1% ointment for patients aged 6 months and older with at least 3% of body surface area affected (excluding palms and soles).

Pedskin Research pediatric dermatology

Request an Appointment

To request an appointment, please fill out the contact form below. Our team will get back to you as soon as possible to confirm your appointment and answer any questions you may have.
We look forward to assisting you.

Dystrophic Epidermolysis Bullosa Treatment
Opt-In

Meet Our Medical Director

Mercedes E. Gonzalez M.D.
Mercedes E. Gonzalez M.D.

Dr. Mercedes E. Gonzalez is a board-certified pediatric dermatologist. After graduating from Emory University, she earned her degree at Rutgers–New Jersey Medical School in 2004. Always drawn to working with children, she accepted the prestigious pediatrics program at the Morgan Stanley Children’s Hospital of New York–Columbia University where she solidified her interest in treating skin disorders. She then completed a dermatology residency followed by a clinical fellowship in pediatric dermatology at the top-ranked New York University (NYU) Department of Dermatology.

Her gentle, child-friendly bedside manner, combined with her broad knowledge of childhood skin diseases and their treatments, make her the preferred pediatric dermatologist in Miami. In addition to practicing medicine, Dr. Gonzalez currently serves as a clinical assistant professor at The FIU Herbert Wertheim School of Medicine and The Phillip Frost Department of Dermatology at Miller School of Medicine.

Dr. Gonzalez serves as the principal investigator on numerous clinical trials and has a special interest in severe skin diseases in children. She lectures regularly at dermatology conferences and to medical students and residents and is the co-editor of 3 dermatology textbooks, including the recently published 2nd edition of Goodheart’s Same Site Differential Diagnosis, and has published over 50 journal articles.

  • Board-certified pediatric dermatologist.

  • Graduated from Emory University.

  • Earned her degree at rutgers–New Jersey Medical School in 2004.

  • Dr. Gonzalez accepted the prestigious pediatrics program at the Morgan Stanley Children’s Hospital of New York–Columbia University where she solidified her interest in treating skin disorders.

  • She then completed a dermatology residency at the top-ranked New York School of Medicine, followed by a clinical fellowship in pediatric dermatology.

Pedskin Research treatment for skin conditions

Frequently Asked Questions

EB is a rare genetic condition that makes the skin extremely fragile, causing blisters and wounds from minor friction or touch.

EB is caused by genetic mutations that affect proteins responsible for skin strength and integrity.

No, EB is a genetic disorder and cannot be spread to others.

Symptoms include blisters, skin erosions, fragile nails, scarring, and, in severe cases, internal complications.

EB is diagnosed through genetic testing.

We provide specialized wound care, protective dressings, pain management strategies, and treatment plans tailored to each child’s needs.We also offer cutting edge research trials that provide access to the latest treatments.

Yes, but they may need special accommodations to protect their skin. Teachers and caregivers should be educated about EB care.

Daily care includes gentle bathing, applying special bandages, managing pain, and avoiding friction.

Currently, there is no cure, but treatment can help manage symptoms and improve quality of life.

Parents can learn proper wound care, use soft clothing, prevent injuries, and seek support from medical professionals and EB organizations.